广泛纳入标准下慢性感染全髋关节置换术的单期无骨水泥翻修:126例患者结果
研究评估广泛纳入标准下采用无骨水泥假体对慢性感染全髋关节置换术行单期翻修的结果。2010至2016年126例患者接受常规单期翻修,髓腔内灌注万古霉素或亚胺培南粉末并植入无骨水泥假体;培养阴性、真菌感染及多重耐药菌感染患者术后行关节腔内病原敏感抗生素直接输注。111例完成随访患者中99例(89.2%)在平均58个月随访时无感染。
要点
- 111例随访患者中99例(89.2%)在平均58个月时无感染。
- 培养阴性感染髋23例中4例(17.4%)出现感染复发。
- 多重耐药菌感染患者成功率为84.2%(16/19)。
核心结论
- 常规单期无骨水泥翻修可作为慢性感染全髋关节置换术的一种可行选择。
- 本研究结果将充实支持常规采用单期翻修治疗慢性感染全髋关节置换术的不断增长的证据体。
研究设计与样本
- 2010年至2016年间,126例患者接受常规单期翻修,采用无骨水泥重建,髓腔内灌注万古霉素粉末或亚胺培南,并重新植入无骨水泥假体。
- 对培养阴性髋、真菌感染及多重耐药菌感染患者,术后行关节腔内病原敏感抗生素直接输注。
- 评估感染复发与临床结局;3例死亡,12例失访(均无已知感染复发),剩余111例(男60例、女51例)平均年龄58.7岁(标准差12.7;范围20至79岁)。
主要发现
- 111例患者中99例(89.2%)在平均随访58个月(范围24至107个月)时无感染。
- 培养阴性感染髋23例中4例(17.4%)出现感染复发。
- 多重耐药菌感染患者成功率为84.2%(16/19)。
- 最近一次评估时平均术后Harris髋关节评分为79.6分(范围63至92分)。
临床怎么用
- 原文结论认为常规单期无骨水泥翻修可作为慢性感染全髋关节置换术的一种可行选择。
局限性
- 3例患者死亡,12例患者(均无已知感染复发)失访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Single-stage revision is not widely pursued due to restrictive inclusion criteria. In this study, we evaluated the results of single-stage revision of chronically infected total hip arthroplasty (THA) using broad inclusion criteria and cementless implants. PATIENTS AND METHODS: Between 2010 and 2016, 126 patients underwent routine single-stage revision with cementless reconstruction with powdered vancomycin or imipenem poured into the medullary cavity and re-implantation of cementless components. For patients with a culture-negative hip, fungal infections, and multidrug-resistant organisms, a direct intra-articular infusion of pathogen-sensitive antibiotics was performed postoperatively. Recurrence of infection and clinical outcomes were evaluated. Three patients died and 12 patients (none with known recurrent infection) were lost to follow-up. There were 111 remaining patients (60 male, 51 female) with a mean age of 58.7 (sd 12.7; 20 to 79). RESULTS: Of these 111 patients, 99 (89.2%) were free of infection at a mean follow-up time of 58 months (24 to 107). A recurrent infection was observed in four of the 23 patients (17.4%) with culture-negative infected hip. The success rate in patients with multidrug-resistant organisms was 84.2% (16/19). The mean postoperative Harris hip score was 79.6 points (63 to 92) at the most recent assessment. CONCLUSION: Routine single-stage revision with cementless reconstruction can be a viable option for the treatment of chronically infected THA. The results of this study will add to the growing body of evidence supporting routine use of single-stage revision for the treatment of chronically infected THA. Cite this article: Bone Joint J 2019;101-B:396-402.
引用
- Ji B, Wahafu T, Li G, et al. Single-stage treatment of chronically infected total hip arthroplasty with cementless reconstruction: results in 126 patients with broad inclusion criteria. Bone Joint J. 2019. PMID: 30929477. doi:10.1302/0301-620X.101B4.BJJ-2018-1109.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。